ID: ALA3228394

Max Phase: Preclinical

Molecular Formula: C6H8BrFN2

Molecular Weight: 126.13

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Br.Cn1cc(F)ccc1=N

Standard InChI:  InChI=1S/C6H7FN2.BrH/c1-9-4-5(7)2-3-6(9)8;/h2-4,8H,1H3;1H

Standard InChI Key:  BNBZSTDIYRQJSP-UHFFFAOYSA-N

Associated Targets(non-human)

INMT Indolethylamine N-methyltransferase (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 126.13Molecular Weight (Monoisotopic): 126.0593AlogP: 0.64#Rotatable Bonds: 0
Polar Surface Area: 28.78Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 11.26CX LogP: 0.45CX LogD: -1.95
Aromatic Rings: 1Heavy Atoms: 9QED Weighted: 0.53Np Likeness Score: -0.90

References

1. Rokach J, Hamel P, Hunter NR, Reader G, Rooney CS, Anderson PS, Cragoe EJ, Mandel LR..  (1979)  Cyclic amidine inhibitors of indolamine N-methyltransferase.,  22  (3): [PMID:423205] [10.1021/jm00189a004]

Source